Navigation Links
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
Date:8/6/2009

s release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.

    SEQUENOM, Inc.
    Condensed Consolidated Financial Statements - June 2009
    (in thousands, except per share data)

    Consolidated Summary of Operations - Q2 to June & YTD June

                             ---------------------      --------------------
                               Three months ended         Six months ended
                                    June 30,                  June 30,
                               2009          2008         2009         2008
                               ====          ====         ====         ====
                           (unaudited)   (unaudited)  (unaudited)  (unaudited)
    Product revenues:
      Consumables             $5,196        $4,940       $9,918       $9,600
      System related           3,295         6,640        6,421       11,152
      Services                   677         1,190        1,514        2,548
      Research and other           -            75            3          120
                                 ---            --          ---          ---
          Total revenues       9,168        12,845       17,856       23,420

    Costs and expenses:
      Costs of product
       and service revenues    3,126         5,462        6,550       10,133
      Research and development
       expenses               10,226         6,413       19,006       11,298
      Selling and marketing
       expenses                6,934         6,326       14,253       12,139
      General and
       administrative
       expenses                8,196         4,252       15,138        7,622
      Restructuring            1,002             -        1,002    
'/>"/>
SOURCE SEQUENOM, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. SEQUENOM Announces Launch of MassARRAY Compact 96 System
2. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
3. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
4. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
5. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
6. OncoGenex Reports Second Quarter 2009 Financial Results
7. Repligen Reports First Quarter Fiscal Year 2010 Financial Results
8. PDI Reports 2009 Second Quarter Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
10. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
11. NxStage Reports Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014 Ontotext S4 , The ... Ontotext . Now the same enterprise hardened text ... and unstructured data is available to start-ups and mid-size ... technology. Organizations that do not have resources to evaluate ... use S4 since there is no need for on ...
(Date:8/20/2014)... Clintrax Global, Inc., a worldwide provider ... Raleigh, NC , recently announced the addition ... of Administration. As Vice President ... including their alignment with company objectives and policies.  ... an HR executive, specializing in needs assessments, customer ...
(Date:8/20/2014)... Aug. 20, 2014 Neurotrope, Inc. (OTCQB: ... conference call to provide an update on Company ... daylight timeDial-in numbers:(888) 505-4369 (U.S. and Canada) or ... cast: www.neurotropebioscience.com , under "Investor Relations"The teleconference replay ... through September 2, 2014 at (888) 203-1112 (U.S. ...
(Date:8/20/2014)... San Francisco, CA (PRWEB) August 20, 2014 ... Medicine Conference is being held on October 29-30 ... fresh perspectives from industry, academic and government researchers and ... remaining in the space. , In the twelve ... than one hundred therapies have been introduced with pharmacogenetic ...
Breaking Biology Technology:Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4Clintrax Global, Inc. Announces Addition to Executive Team 2Neurotrope To Host Conference Call 26th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2
... Waukesha, Wis. - GE Healthcare has ... Research Excellence in Breast Cancer Imaging within the ... , ,With funding from GE Healthcare, a $17 billion ... is designed to advance and commercialize research and technology ...
... a meeting with U.S. Health and Human Services ... and healthcare organizations pledged to support health information technology ... health information technology products used by their health plans. ... effort to support a national initiative aimed at improving ...
... admitted his crystal ball may be a little cloudy, but he ... woes may have already trickled out in anticipation of the ... his Senate colleague and a software executive, isn`t sure the worst ... that the audit on state IT projects should be a catalyst ...
Cached Biology Technology:Wisconsin firms pledge to support healthcare IT standards 2Is the worst over for state technology failures? 2
(Date:8/21/2014)... Researchers from North Carolina State University have developed a ... The model has applications for creating new materials as ... , "Our new technique allows us to model much ... so much more quickly," says Nan Li, lead author ... student in NC State,s Department of Materials Science and ...
(Date:8/20/2014)... (HCI) at the University of Utah have identified and ... the unregulated enzyme driving the blood cancer chronic myeloid ... 6,000 new cases of CML will be diagnosed in ... inhibitors (TKIs), target BCR-ABL and are effective at controlling ... it in a way that allows patients to get ...
(Date:8/20/2014)... this image of the Para and Mato Grosso states ... intentionally set in order to deforest the land. Deforestation ... trees where the land is thereafter converted to a ... to farms, ranches, or urban use. The herringbone-patterned tan ... Rainforest in the middle of the image are evidence ...
Breaking Biology News(10 mins):Researchers develop models to study polyelectrolytes, including DNA and RNA 2Blueprint for next generation of chronic myeloid leukemia treatment 2
... forming the droplets that make up clouds, a little ... much. And that,s good news for reducing the uncertainty ... essential for accurate climate modeling, and understanding cloud formation ... form when water vapor is attracted to particles floating ...
... name by successfully transplanting bioengineered stem cell-based trachea, composed of ... the technique to recreate more complex tissues, such as the ... lungs. He has also made an experimental attempt to regenerate ... news he will be presenting during his seminar at the ...
... national synchrotron facility, Diamond Light Source, is now the first ... 3 including serious viruses such as those responsible for ... analysed at atomic and molecular level using synchrotron light. This ... levels of detail and this new facility extends that capability ...
Cached Biology News:The role of goop: Research shows pollution doesn't change the rate of droplet formation 2The role of goop: Research shows pollution doesn't change the rate of droplet formation 3Stem cell-based bioartificial tissues and organs 2Diamond sheds light on basic building blocks of life 2Diamond sheds light on basic building blocks of life 3
... anti-Cytohesin 2, Monoclonal Antibody, Unconjugated ... dependent dilution. ICC: Use at an assay dependent ... - 10 ug/ml, this concentration is determined using ... weight: 40 kDa. Not tested in other applications. ...
Recognizes TWIK-2. Does not cross react with any other known proteins....
Anti human PPAR gamma2 mouse monoclonal antibody...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Biology Products: